by Team Small News | Oct 7, 2025 | Dr Reddy's
On Monday, Donald Trump will be inaugurated for his second term as the President of the United States. The event is expected to be a significant one, with several key activities and attendees. Trump plans to sign numerous executive orders on his first day in office,... by Team Small News | Oct 7, 2025 | Biocon, Pharma
Biocon, a biopharmaceutical company, has agreed to a settlement with Amgen, a multinational biotechnology company, regarding the biosimilars of Prolia and Xgeva. Prolia and Xgeva are two popular medications developed by Amgen, used to treat osteoporosis and prevent... by Team Small News | Oct 7, 2025 | Pharma
The White House has unveiled a comprehensive plan to tackle the nation’s drug crisis, but critics argue that it has some notable blind spots. The plan, which focuses on combating the opioid epidemic, improving treatment access, and reducing drug trafficking, has...
by Team Small News | Oct 7, 2025 | Pharma, Zydus
Zydus, a leading Indian pharmaceutical company, has received approval from the US Food and Drug Administration (USFDA) for a new drug. This approval is a significant milestone for the company, as it demonstrates its ability to develop and manufacture high-quality... by Team Small News | Oct 7, 2025 | Mankind, Pharma
The Delhi High Court has granted an ex-parte ad-interim injunction in favor of Mankind Pharma Limited, a leading pharmaceutical company in India, to protect its well-established “Kind” family of marks. The court’s decision was made in response to the...